Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ghanashyam, Sarikonda"'
Autor:
Arjun Khunger, Ghanashyam Sarikonda, Jennifer Tsau, Anil Pahuja, Zeni Alfonso, Jane Gao, Christian Laing, Christine Vaupel, Naveen Dakappagari, Ahmad A. Tarhini
Publikováno v:
Translational Oncology, Vol 14, Iss 3, Pp 101014- (2021)
Neoadjuvant therapy with ipilimumab in combination with high dose IFNα was evaluated in patients with locally/regionally advanced melanoma in a previously reported clinical trial [NCT01608594]. In this study, peripheral immune cell profiling was per
Externí odkaz:
https://doaj.org/article/099a2088a9b64bcebb0642fdaabb7971
Autor:
Sema Kurtulus, David Quinn, Jennifer Mataraza, Jennifer Tsau, Brittney Atzmiller, Tanya Mulvey, Ghanashyam Sarikonda
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8ca70185040d40fd888ee5dc97fae1b5
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Treatment significantly affects the circulating immune compartment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eeb4ff31ce1f39f892e656546912333
https://doi.org/10.1158/1078-0432.22481585
https://doi.org/10.1158/1078-0432.22481585
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Representative gating strategy illustrating (A) CD4 and CD8 T cell identification (B) expression of ICOS on CD4 positive T cells (C) expression of PD-1 and Ki-67 within PD-1 positive cells and (D) expression of CD38/HLA-DR, PD-1 and KI-67 within CD8+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05be2d07b58f4dfd685805c3833c030c
https://doi.org/10.1158/1078-0432.22481579.v1
https://doi.org/10.1158/1078-0432.22481579.v1
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Treatment significantly affects the circulating immune compartment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf8661283efc187904b5f5fcda67641
https://doi.org/10.1158/1078-0432.22481576.v1
https://doi.org/10.1158/1078-0432.22481576.v1
Data from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Autor:
Ahmad A. Tarhini, John M. Kirkwood, Hassane M. Zarour, Amy Rose, Cindy Sander, Matthew P. Holtzman, James F. Pingpank, Christian Laing, Zeni Alfonso, Jennifer Tsau, Anil Pahuja, Ghanashyam Sarikonda, Beiru Chen, Ju Young Kim, Jehovana O. Bender, IlaSri B. Summit, Jennifer Bordeaux, Joseph J. Skitzki, Igor Puzanov, Marc S. Ernstoff, Lisa H. Butterfield, Rogerio I. Neves, Joseph J. Drabick, Arivarasan Karunamurthy, Diwakar Davar, Yan Zang, Yan Lin, Huang Lin, Dustin McCurry, Yana G. Najjar
Purpose:Neoadjuvant immunotherapy may improve the clinical outcome of regionally advanced operable melanoma and allows for rapid clinical and pathologic assessment of response. We examined neoadjuvant pembrolizumab and high-dose IFNα-2b (HDI) therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1471b78d10ef705c6b751e83f0d0d685
https://doi.org/10.1158/1078-0432.c.6530735.v1
https://doi.org/10.1158/1078-0432.c.6530735.v1
Autor:
Jennifer Bordeaux, Dustin McCurry, Arivarasan Karunamurthy, Lisa H. Butterfield, Rogerio I. Neves, Anil Pahuja, Matthew P. Holtzman, Beiru Chen, Jehovana Orozco Bender, Ahmad A. Tarhini, Yan Zang, Ju Young Kim, John M. Kirkwood, Yan Lin, Cindy Sander, Joseph J. Skitzki, IlaSri B. Summit, Marc S. Ernstoff, Christian Laing, Joseph J. Drabick, Yana G. Najjar, Huang Lin, Jennifer Tsau, Ghanashyam Sarikonda, Igor Puzanov, Hassane M. Zarour, Zeni Alfonso, Amy Rose, James F. Pingpank, Diwakar Davar
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 15
Purpose:Neoadjuvant immunotherapy may improve the clinical outcome of regionally advanced operable melanoma and allows for rapid clinical and pathologic assessment of response. We examined neoadjuvant pembrolizumab and high-dose IFNα-2b (HDI) therap
Autor:
Swati Gupta, Sylvie Bertholet, Daniela Verthelyi, Jason Delcarpini, George R Gunn, Richard Siggers, Anna Ma, Fabio Garofolo, Lisa Kierstead, Mark Milton, Francis Dessy, Johann Poetzl, Arno Kromminga, Boris Gorovits, Marco Petrillo, Madeleine Dahlbäck, Lynne Jesaitis, Robert J Kubiak, Becky Schweighardt, Mohsen Rajabi Abhari, Kay Stubenrauch, Meina Liang, Yanmei Lu, Susan Kirshner, Haoheng Yan, John Kamerud, Rocio Murphy, Naveen Dakappagari, Holger Koch, Akiko Ishii-Watabe, Yuanxin Xu, Sam Song, Michael A Partridge, Lucia Zhang, Chris Stebbins, Vibha Jawa, Andrew Exley, Elana Cherry, Jim McNally, Manoj Rajadhyaksha, Bart Corsaro, Bonnie Wu, Therese Solstad, Jean-Claude Marshall, Isabelle Cludts, Ivo Sonderegger, Sumit Kar, Tong-Yuan Yang, Roland F Staack, João Pedras-Vasconcelos, Natasha Savoie, Yuling Wu, Samuel O. Pine, Ghanashyam Sarikonda
Publikováno v:
Bioanalysis. 13:415-463
The 14th edition of the Workshop on Recent Issues in Bioanalysis (14th WRIB) was held virtually on June 15-29, 2020 with an attendance of over 1000 representatives from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract res
Autor:
Reinhold Pollner, Ghanashyam Sarikonda, Kevin Nguyen, Anil Pahuja, Creton Kalfoglou, Kerri Burns, Naveen Dakappagari, Irene L. Ch’en, Shabnam Tangri
Publikováno v:
Cytometry Part B: Clinical Cytometry. 100:72-78
Exceptional clinical responses produced by the first chimeric antigen receptor T [CAR-T] cell therapies, and their entry into commercial markets prompted a logarithmic increase in the number of next generation CAR-T clinical trials. As a result, ther
Autor:
Ghanashyam Sarikonda, Georgia Fousteri, Sowbarnika Sachithanantham, Jacqueline F Miller, Amy Dave, Therese Juntti, Ken T Coppieters, Matthias von Herrath
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112242 (2014)
The infusion of ex vivo-expanded autologous T regulatory (Treg) cells is potentially an effective immunotherapeutic strategy against graft-versus-host disease (GvHD) and several autoimmune diseases, such as type 1 diabetes (T1D). However, in vitro di
Externí odkaz:
https://doaj.org/article/e87af32233064d9d86e31b3da2999a3f